Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Non – Hodgkin Lymphoma Therapeutics Market to reach USD 16.0 billion by the end of 2029

Global Non - Hodgkin Lymphoma Therapeutics Market Size study & Forecast, by Type of Therapy (Immunotherapy, Chemotherapy, Targeted Therapy and Others) by Disease Type (B- Cell Lymphoma and T-cell Lymphoma), by Distribution Channel (Hospitals, Retail Pharmacies, Others) and Regional Analysis, 2022-2029

Product Code: HLSDT-52890911
Publish Date: 20-03-2023
Page: 200

Global Non – Hodgkin Lymphoma Therapeutics Market is valued at approximately USD 8.33 billion in 2021 and is anticipated to grow with a healthy growth rate of around 8.50% over the forecast period 2022-2029. Non- Hodgkin lymphoma (NHL) is a condition where abnormal lymphocytes are produced in the human body. These lymphocytes do not die and keep growing and dividing within the body unless treated. NHL is generally located at lymph nodes, however, if not treated in time, then it might spread to the entire lymphatic system. The Non- Hodgkin lymphoma therapeutics market is subdivided on basis of type, treatment type, route of administration, distribution channel and end user. The market growth of industries will get inspected from the growth of these segments and help the users to overview you the market insights and helps to make decisions for classifying core market application.

Increasing events of Non-Hodgkin Lymphomas lead to Market Growth and are the current trends of higher prevalence of almost all types of cancer which also includes several types of NHL The need for better clinical and remedial results for the patients for non-Hodgkin lymphoma where the disease has become refractory or deteriorated is a critical driving factor. Ongoing and increased R&D activity in the development of efficient therapeutics for a number of types of NHL are one of the key driving factors. Along with an increasing investment by market players also a factor for long term growth. The rising demand for oral drugs has also contributed to the market growth where most products are available in capsule and tablet form.

Increased cost of approved Therapeutics in Emerging countries leads to curb the Adoption of advanced Therapeutics. The non-Hodgkin lymphoma treatment market growth is affected by the high cost imputed to certain types of therapies like immunotherapies. Lack of trained professionals who are unaware of the knowledge of the treatment methods for this disease could curb the growth of the global non-Hodgkin lymphoma market over a forecast period.

As Health Awareness increasing among the population also indicates a major boost to the market growth. According to the American Cancer Society, non-Hodgkin lymphoma is estimated to be around 80, 470. The Highest rates are likely to be in the age group between 80-84 years for females and 85-89 years for males. The need for better clinical are required more and more to treat the patients effectively which drives the market growth.

The key regions considered for the Global Non – Hodgkin Lymphoma Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominates the market due to high prevalence and awareness of all forms of cancer including various blood cancers such as non-Hodgkin’s lymphoma. These led to adoption of expensive form of therapies for treatment of NHL such as immunotherapies. Asia Pacific is going to be the fastest growing market in the forecasted period, Japan in Asia Pacific has approved the expensive therapeutics such as KYMRIAH which holds strong population base and well contribute in the Asia Pacific market growth.
Major market player included in this report are:
Takeda Pharmaceutical Company Limited
AstraZeneca plc
Bayer AG
Novartis AG
Kyowa Kirin Co. Ltd.
Bristol Myers Squibb Company
Janssen Pharmaceuticals Inc.
Merck & Co., Inc.
Sanofi India
AbbVie Inc.

Recent Developments in the Market:
 April 2021 – Kyowa Kirin Co., Ltd. and MEI Pharma Inc. announced the completion of patient enrollment in the global Phase 2 TIDAL study in the primary efficacy follicular lymphoma population.
 April 2021 – Kyowa Kirin Co., Ltd. and MEI Pharma Inc. announced the completion of patient enrollment in the gl primary efficacy population for follicular lymphoma.  February 2021 – Bristol-Myers Squibb Company Receives FDA Approval of CAR T-Cell Therapy Breyanzi for the Treatment of Large B-Cell Lymphoma in Patients Who Relapsed After Two Other Systematic Treatments or Responded to Previous Therapy announced that it had received Treatment has not been addressed.
 December 2020 – AstraZeneca announced that Calquence, an anti-cancer drug used to treat patients with mantle cell lymphoma, has shown positive responses in a Phase 2 clinical trial.

Global Non – Hodgkin Lymphoma Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered By Therapy, Disease Type, Distribution channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy:
Targeted Therapy

By Disease Type:
B-cell Lymphoma
T-cell Lymphoma

By Distribution Channel:
Retail Pharmacies

By Region:
North America
Asia Pacific
South Korea
Latin America
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Non-Hodgkin lymphoma treatment Market, by Region, 2019-2029 (USD Billion)
1.2.2. Non-Hodgkin lymphoma treatment Market, by Therapy, 2019-2029 (USD Billion)
1.2.3. Non-Hodgkin lymphoma treatment Market, by Disease, 2019-2029 (USD Billion)
1.2.4. Non-Hodgkin lymphoma treatment Market, by Distribution, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Non-Hodgkin lymphoma treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Non-Hodgkin lymphoma treatment Market Dynamics
3.1. Non-Hodgkin lymphoma treatment Market Impact Analysis (2019-2029)
3.1.1. Market Drivers Increasing investments by Market players Rising Demand for oral drugs
3.1.2. Market Challenges High Cost of Non-Hodgkin lymphoma treatment
3.1.3. Market Opportunities Increase in Non-Hodgkin Lymphoma Rising Healthcare Awareness
Chapter 4. Global Non-Hodgkin lymphoma treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Non-Hodgkin lymphoma treatment Market, by Therapy
6.1. Market Snapshot
6.2. Global Non-Hodgkin lymphoma treatment Market by Therapy, Performance – Potential Analysis
6.3. Global Non-Hodgkin lymphoma treatment Market Estimates & Forecasts by Therapy 2019-2029 (USD Billion)
6.4. Non-Hodgkin lymphoma treatment Market, Sub Segment Analysis
6.4.1. Chemotherapy
6.4.2. Targeted Therapy
6.4.3. Immunotherapy
6.4.4. Others
Chapter 7. Global Non-Hodgkin lymphoma treatment Market, by Disease type
7.1. Market Snapshot
7.2. Global Non-Hodgkin lymphoma treatment Market by Disease type, Performance – Potential Analysis
7.3. Global Non-Hodgkin lymphoma treatment Market Estimates & Forecasts by Disease type 2019-2029 (USD Billion)
7.4. Non-Hodgkin lymphoma treatment Market, Sub Segment Analysis
7.4.1. B-Cell Lymphoma
7.4.2. T-cell Lymphoma
Chapter 8. Global Non-Hodgkin lymphoma treatment Market, by Distribution channel
8.1. Market Snapshot
8.2. Global Non-Hodgkin lymphoma treatment Market by Distribution channel, Performance – Potential Analysis
8.3. Global Non-Hodgkin lymphoma treatment Market Estimates & Forecasts by Distribution channel 2019-2029 (USD Billion)
8.4. Non-Hodgkin lymphoma treatment Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail pharmacies
8.4.3. Others
Chapter 9. Global Non-Hodgkin lymphoma treatment Market, Regional Analysis
9.1. Non-Hodgkin lymphoma treatment Market, Regional Market Snapshot
9.2. North America Non-Hodgkin lymphoma treatment Market
9.2.1. U.S. Non-Hodgkin lymphoma treatment Market Therapy breakdown estimates & forecasts, 2019-2029 Disease type breakdown estimates & forecasts, 2019-2029 Distribution channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Non-Hodgkin lymphoma treatment Market
9.3. Europe Non-Hodgkin lymphoma treatment Market Snapshot
9.3.1. U.K. Non-Hodgkin lymphoma treatment Market
9.3.2. Germany Non-Hodgkin lymphoma treatment Market
9.3.3. France Non-Hodgkin lymphoma treatment Market
9.3.4. Spain Non-Hodgkin lymphoma treatment Market
9.3.5. Italy Non-Hodgkin lymphoma treatment Market
9.3.6. Rest of Europe Non-Hodgkin lymphoma treatment Market
9.4. Asia-Pacific Non-Hodgkin lymphoma treatment Market Snapshot
9.4.1. China Non-Hodgkin lymphoma treatment Market
9.4.2. India Non-Hodgkin lymphoma treatment Market
9.4.3. Japan Non-Hodgkin lymphoma treatment Market
9.4.4. Australia Non-Hodgkin lymphoma treatment Market
9.4.5. South Korea Non-Hodgkin lymphoma treatment Market
9.4.6. Rest of Asia Pacific Non-Hodgkin lymphoma treatment Market
9.5. Latin America Non-Hodgkin lymphoma treatment Market Snapshot
9.5.1. Brazil Non-Hodgkin lymphoma treatment Market
9.5.2. Mexico Non-Hodgkin lymphoma treatment Market
9.6. Rest of The World Non-Hodgkin lymphoma treatment Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Takeda Pharmaceutical Company Limited Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
10.2.2. AstraZeneca plc
10.2.3. Bayer AG
10.2.4. Novartis AG
10.2.5. Kyowa Kirin Co. Ltd.
10.2.6. Bristol Myers Squibb Company
10.2.7. Janssen Pharmaceuticals Inc.
10.2.8. Merck & Co. Inc.
10.2.9. Sanofi India
10.2.10. AbbVie. Inc

Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now